Oct 23, 2020
By Jane Brown
The first drug designed to treat COVID-19 has been approved by the U.S. Food and Drug Administration.
(In this March 2020 photo provided by Gilead Sciences, a vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. Gilead Sciences via AP)
Remdesivir is an anti-viral medicine given intravenously.
A statement from Remdesivir’s maker, California-based Gilead Sciences Inc., says it’s approved for people at least 12 years of age who need hospitalization for their coronavirus infection.
A large study stateside found it cut the time to recovery by five days, from 15 days to 10 on average.
It works by inhibiting a substance the virus uses to make copies of itself.
It had been authorized for use on an emergency basis since spring, and now has become the first drug to win full U.S. approval for treating COVID-19.